Rating History for Contineum Therapeutics (CTNM) by Baird

More Stocks Rated by Baird | Latest Ratings for CTNM
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/13/2026 Joel Beatty Downgrade Neutral
(Outperform)		 14.00
(19.00)		 8.57
(7.08)		 -17.39% Details